【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 2290次   下载 1784 本文二维码信息
码上扫一扫!
黄芩苷体外抑制氟尿嘧啶耐药肝癌细胞的生长及作用机制
郭霞1,郭昱2
0
(1.河北医科大学第四医院消化内科,石家庄 050011;2.河北医科大学第二医院消化内科,石家庄 050000)
摘要:
目的:观察黄芩苷体外对氟尿嘧啶(Fu)耐药肝癌细胞株生长的影响,并探讨其可能的作用机制。方法:体外培养人肝癌细胞BEL-7402及其耐药细胞BEL-7402/5-Fu,MTT法观察黄芩苷作用后细胞增殖情况;流式细胞术测定细胞内罗丹明123荧光强度;RT-PCR检测细胞多重耐药MDR1基因表达;Western印迹法检测细胞P-gp蛋白表达;应用Matrigel模型测定细胞黏附率;荧光免疫技术测定细胞β1-整合素(β1-integrin)和上皮钙黏附素(E-CD)蛋白表达。结果:黄芩苷明显抑制肝癌细胞BEL-7402及其耐药细胞BEL-7402/5-Fu的增殖,IC50分别为34.2、36.6 mg/L。5、10 mg/L黄芩苷能部分逆转耐药细胞对Fu的耐药,逆转倍数分别为28.6、46.7;5、10 mg/L黄芩苷增强BEL-7402对Fu敏感性,增敏倍数分别为1.4、2.1。5、10 mg/L黄芩苷增加耐药细胞内药物积聚,降低MDR1基因及P-gp蛋白表达,抑制耐药细胞黏附率,降低耐药细胞β1-整合素表达,促进E-CD蛋白表达;且10 mg/L黄芩苷效果优于5 mg/L(P均<0.05)。结论:黄芩苷体外能抑制肝癌细胞生长及降低细胞黏附性,并能部分恢复肝癌耐药细胞对Fu的敏感性,这可能与其增加细胞内药物浓度、抑制MDR1基因表达有关。
关键词:  黄芩苷  肝肿瘤  氟尿嘧啶  抗肿瘤药耐药性
DOI:10.3724/SP.J.1008.2008.00025
投稿时间:2007-10-08修订日期:2007-12-19
基金项目:河北省科技支撑计划项目(072461478D).
Inhibitory effect of baicalin on fluorouracil resistant HCC cell line BEL-7402/5-Fu and its possible mechanism
GUO Xia1, GUO Yu2
(1.Department of Gastroenterology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China;2.Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000)
Abstract:
Objective:To investigate the inhibitory effect of baicalin on the fluorouracil (Fu) resistant hepatocarcinoma cell(HCC) BEL-7402/5-Fu and its possible mechanism. Methods:Hepatocarcinoma cell line BEL-7402 and Fu-resistant hepatocarcinoma cell line BEL-7402/5-Fu were cultured in vitro. The inhibitory effect of baicalin on the BEL-7402/5-Fu cells was assessed by MTT assay; the intracellular rhodamine fluorescence intensity was observed by flow cytometry; the expression of MDR1 gene was detected by RT-PCR; and the expression of protein P-glycoprotein (P-gp) was analyzed by Western blotting assay. Adhesion assay was conducted using Matrigel model. Expression of beta 1-integrin and E-CD protein was detected by immunofluorescence technique. Results:Baicalin inhibited the proliferation of both BEL-7402 and BEL-7402/5-Fu cells, with IC50 of baicalin being 34.2 mg/L and 36.6 mg/L, respectively. Baicalin (5 mg/L and 10 mg/L) partially reversed the resistance of BEL-7402/5-Fu to Fu, with the reversal folds being 28.6 and 46.7, respectively. Baicalin (5 mg/L and 10 mg/L) increased the sensitivity of BEL-7402 cells to Fu, with the sensitivity-enhancing folds being 1.4 and 2.1, respectively. Baicalin also increased the concentration of rhodamine and expression of integrin β1, inhibited the expression of MDR1 gene and P-gp, E-CD protein, and reduced the adhesion capacity, with the effect of 10 mg/L baicalin significantly effective than that of 5 mg/L baicalin (all P<0.05).Conclusion:Baicalin can inhibit the proliferation of BEL-7402/5-Fu in vitro, and partially reverse the resistance to Fu, which is attributable to the increased accumulation of intracellular drug concentration, inhibited expression of MDR1 gene.
Key words:  baicalin  liver neoplasm  fluorouracil  antineoplastic drug resistance